
Genomma Lab Internacional SAB de CV
BMV:LABB

Genomma Lab Internacional SAB de CV?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
14.08
28.88
|
Price Target |
|
We'll email you a reminder when the closing price reaches MXN.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Genomma Lab Internacional SAB de CV hold over its rivals?
What risks and challenges
does Genomma Lab Internacional SAB de CV face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Genomma Lab Internacional SAB de CV.
Provide an overview of the primary business activities
of Genomma Lab Internacional SAB de CV.
What unique competitive advantages
does Genomma Lab Internacional SAB de CV hold over its rivals?
What risks and challenges
does Genomma Lab Internacional SAB de CV face in the near future?
Summarize the latest earnings call
of Genomma Lab Internacional SAB de CV.
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Genomma Lab Internacional SAB de CV.
Provide P/S
for Genomma Lab Internacional SAB de CV.
Provide P/E
for Genomma Lab Internacional SAB de CV.
Provide P/OCF
for Genomma Lab Internacional SAB de CV.
Provide P/FCFE
for Genomma Lab Internacional SAB de CV.
Provide P/B
for Genomma Lab Internacional SAB de CV.
Provide EV/S
for Genomma Lab Internacional SAB de CV.
Provide EV/GP
for Genomma Lab Internacional SAB de CV.
Provide EV/EBITDA
for Genomma Lab Internacional SAB de CV.
Provide EV/EBIT
for Genomma Lab Internacional SAB de CV.
Provide EV/OCF
for Genomma Lab Internacional SAB de CV.
Provide EV/FCFF
for Genomma Lab Internacional SAB de CV.
Provide EV/IC
for Genomma Lab Internacional SAB de CV.
Show me price targets
for Genomma Lab Internacional SAB de CV made by professional analysts.
What are the Revenue projections
for Genomma Lab Internacional SAB de CV?
How accurate were the past Revenue estimates
for Genomma Lab Internacional SAB de CV?
What are the Net Income projections
for Genomma Lab Internacional SAB de CV?
How accurate were the past Net Income estimates
for Genomma Lab Internacional SAB de CV?
What are the EPS projections
for Genomma Lab Internacional SAB de CV?
How accurate were the past EPS estimates
for Genomma Lab Internacional SAB de CV?
What are the EBIT projections
for Genomma Lab Internacional SAB de CV?
How accurate were the past EBIT estimates
for Genomma Lab Internacional SAB de CV?
Compare the revenue forecasts
for Genomma Lab Internacional SAB de CV with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Genomma Lab Internacional SAB de CV and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Genomma Lab Internacional SAB de CV against its competitors.
Analyze the profit margins
(gross, operating, and net) of Genomma Lab Internacional SAB de CV compared to its peers.
Compare the P/E ratios
of Genomma Lab Internacional SAB de CV against its peers.
Discuss the investment returns and shareholder value creation
comparing Genomma Lab Internacional SAB de CV with its peers.
Analyze the financial leverage
of Genomma Lab Internacional SAB de CV compared to its main competitors.
Show all profitability ratios
for Genomma Lab Internacional SAB de CV.
Provide ROE
for Genomma Lab Internacional SAB de CV.
Provide ROA
for Genomma Lab Internacional SAB de CV.
Provide ROIC
for Genomma Lab Internacional SAB de CV.
Provide ROCE
for Genomma Lab Internacional SAB de CV.
Provide Gross Margin
for Genomma Lab Internacional SAB de CV.
Provide Operating Margin
for Genomma Lab Internacional SAB de CV.
Provide Net Margin
for Genomma Lab Internacional SAB de CV.
Provide FCF Margin
for Genomma Lab Internacional SAB de CV.
Show all solvency ratios
for Genomma Lab Internacional SAB de CV.
Provide D/E Ratio
for Genomma Lab Internacional SAB de CV.
Provide D/A Ratio
for Genomma Lab Internacional SAB de CV.
Provide Interest Coverage Ratio
for Genomma Lab Internacional SAB de CV.
Provide Altman Z-Score Ratio
for Genomma Lab Internacional SAB de CV.
Provide Quick Ratio
for Genomma Lab Internacional SAB de CV.
Provide Current Ratio
for Genomma Lab Internacional SAB de CV.
Provide Cash Ratio
for Genomma Lab Internacional SAB de CV.
What is the historical Revenue growth
over the last 5 years for Genomma Lab Internacional SAB de CV?
What is the historical Net Income growth
over the last 5 years for Genomma Lab Internacional SAB de CV?
What is the current Free Cash Flow
of Genomma Lab Internacional SAB de CV?
Discuss the annual earnings per share (EPS)
trend over the past five years for Genomma Lab Internacional SAB de CV.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
MX |
![]() |
Genomma Lab Internacional SAB de CV
BMV:LABB
|
22.4B MXN | 1.3 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
699.5B USD | 15.5 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
368.8B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 6.6 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
208.7B CHF | 3.6 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
167.6B GBP | 4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
186.3B CHF | 4.2 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
206.3B USD | 3.2 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
162.4B USD | 70 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
119.8B EUR | 2.7 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
MX |
![]() |
Genomma Lab Internacional SAB de CV
BMV:LABB
|
Average P/S:
63
1.3
|
10%
|
0.1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
15.5
|
23%
|
0.7 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
3%
|
1.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
6.6
|
17%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.6
|
5%
|
0.7 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
4
|
7%
|
0.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.2
|
3%
|
1.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.2
|
5%
|
0.6 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
70
|
N/A | N/A |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
2.7
|
6%
|
0.5 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.